Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: Is it possible to identify a clinically-aggressive subset of benign meningiomas? Commentary
In Situ Hybridization, Fluorescence
Magnetic Resonance Spectroscopy
Distinct molecular genetic and biochemical alterations differentiated clinically-aggressive Grade I meningiomas from clinically-benign Grade I meningiomas.